鲁斯费尔提德迅速降低血红素在低于最佳控制的真菌多细胞血症患者
Lee Ping Chew1, Yelena Z Ginzburg2, Kamini Kirubamoorthy3
1Hospital Umum Sarawak, Malaysia.
Leukemia research
|November 1, 2025
概括
鲁斯费尔提德通过降低高血红素水平,有效地管理多细胞血症 (PV),减少了需要瘤切除的需要. 这种hepcidin模拟剂提供快速和持续的控制,改善患者的结果.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 血清多细胞 (PV) 是一种骨髓增殖性新生体,其特征是红细胞,白细胞和血小板的过度生产.
- 升高的血红素在PV增加了血栓和心血管事件的风险.
- 目前的治疗方法往往涉及瘤切除,这可能导致缺铁.
研究的目的:
- 评估Rusfertide在患有多细胞血病 (PV) 和基线血红素升高的患者中的疗效和安全性.
- 评估rusfertide降低血红素水平的能力和需要进行瘤切除术.
- 为了监测与rusfertide治疗相关的治疗出现的不良事件.
主要方法:
- 一项开放的2期研究招募了20名患者,PV和基线血红素>48%.
- 患者每周两次接受40毫克皮下鲁斯费尔提德,一旦血红素<45%,过渡到每周一次剂量.
- 通过血红素计数,血红素位数降低和缺铁标志物来衡量有效性. 通过不良事件监测来评估安全性.
主要成果:
- 85%的患者在第8周达到血红素值<45%,达到目标的中位时间为4.9周.
- 在整个研究过程中,血红素水平始终低于45%,因此所有患者都不需要进行瘤切除术.
- 鲁斯弗泰德显著降低了红细胞数量,改善了缺铁标志物,大多数不良事件为1/2级.
结论:
- 鲁斯弗蒂德在患有PV的患者中显示出快速和持续的血红素控制.
- 这种治疗减少了对瘤手术的需要,并改善了血液学参数.
- 鲁斯费尔提德的耐受性一般很好,这表明它在减少血栓事件方面具有潜在的长期益处.
更多相关视频
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
20.3K
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.9K
相关概念视频
01:27Disorders of Erythrocytes
2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
01:11Renal Failure: Dose Adjustments
426
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
426
01:24Factors Affecting Erythropoiesis
5.4K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.4K
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
168
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
168
01:30Continuous Renal Replacement Therapy
789
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
789
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
202
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
202